Back to search

Diltiazem reduces pulmonary arterial pressures in recurrent pulmonary hypertension associated with pulmonary hypoplasia

Data up to Jan 2025

Published1999
Citations13
References10

Total Citations Per Year

Abstract

References (10)

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

1987 • 365 citations

The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension

1989 • 188 citations

Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.

1993 • 77 citations

Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension

1993 • 40 citations

Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension

1989 • 33 citations

Nitric oxide reversal of recurrent pulmonary hypertension and respiratory failure in an infant with CDH after successful ECMO therapy

1995 • 26 citations

Congenital diaphragmatic hernia: impact of prostanoids in the perioperative period.

1990 • 21 citations

Differential Therapy with Calcium Antagonists in Pulmonary Hypertension Secondary to COPD

1990 • 20 citations

Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension

1995 • 12 citations

Effects of Single Intravenous Administration of Urapidil and Diltiazem in Patients with Nonfixed Pulmonary Hypertension Secondary to Chronic Obstructive Lung Disease

1994 • 6 citations

Cited By (0)

Loading...